Alert: House Oversight Committee Chairman Intends To Investigate FDA Inaction On Hemp-Derived CBD And Other Areas Of Jurisdiction

WASHINGTON D.C. — Rep. James Comer (R-KY), Chairman of the U.S. House Oversight Committee, announced his intentions to investigate the U.S. Food and Drug Administration (FDA) for its inaction on critical issues falling within the agency’s regulatory jurisdiction such as hemp-derived CBD and medical devices. In a recent interview with U.S. Hemp Roundtable General Counsel, Jonathan Miller, Comer expressed his intentions to bring FDA Commissioner, Robert Califf, before his committee for questioning.